Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland

Depressive Disorder ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Major Depressive ◽

Treatment Switch

Cost-Utility Analysis of a Collaborative Care Intervention for Major Depressive Disorder in an Occupational Healthcare Setting

Journal of Occupational Rehabilitation ◽

10.1007/s10926-013-9483-4 ◽

2013 ◽

Vol 24 (3) ◽

pp. 555-562 ◽

Cited By ~ 13

Author(s):

Maartje Goorden ◽

Moniek C. Vlasveld ◽

Johannes R. Anema ◽

Willem van Mechelen ◽

Aartjan T. F. Beekman ◽

...

Keyword(s):

Depressive Disorder ◽

Collaborative Care ◽

Healthcare Setting ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Major Depressive ◽

Care Intervention ◽

Occupational Healthcare

A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder

Current Medical Research and Opinion ◽

10.1185/030079908x273309 ◽

2008 ◽

Vol 24 (4) ◽

pp. 1115-1121 ◽

Cited By ~ 12

Author(s):

Edward P. Armstrong ◽

Daniel C. Malone ◽

M. Haim Erder

Keyword(s):

Depressive Disorder ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

PMH21 COST-UTILITY ANALYSIS OF ANTIDEPRESSANTS FOR SECOND-LINE TREATMENT OF MAJOR DEPRESSIVE DISORDER

Value in Health ◽

10.1016/s1098-3015(10)63553-x ◽

2006 ◽

Vol 9 (6) ◽

pp. A316

Author(s):

DC Malone

Keyword(s):

Depressive Disorder ◽

Cost Utility ◽

Cost Utility Analysis ◽

Line Treatment ◽

Second Line ◽

Utility Analysis ◽

Cost-Utility Analysis Evaluating Vortioxetine Versus Venlafaxine XR and Agomelatine in the Treatment of Major Depressive Disorder in Taiwan

Value in Health ◽

10.1016/j.jval.2016.08.531 ◽

2016 ◽

Vol 19 (7) ◽

pp. A841-A842

Author(s):

M Brignone ◽

K Atsou ◽

C Reynaud-Mougin ◽

W Chen ◽

D Milea

Keyword(s):

Depressive Disorder ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

PMH41 COST-UTILITY ANALYSIS OF ESCITALOPRAM VERSUS CITALOPRAM IN MAJOR DEPRESSIVE DISORDER IN ISRAEL

Value in Health ◽

10.1016/s1098-3015(11)72918-7 ◽

2010 ◽

Vol 13 (7) ◽

pp. A453

Author(s):

M Leshno ◽

Y Ben-Amnon ◽

M Brignone ◽

F Marteau ◽

K Hansen

Keyword(s):

Depressive Disorder ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder

International Journal of Clinical Practice ◽

10.1111/j.1742-1241.2008.01711.x ◽

2008 ◽

Vol 62 (4) ◽

pp. 623-632 ◽

Cited By ~ 15

Author(s):

P. Sobocki ◽

M. Ekman ◽

A. Ovanfors ◽

R. Khandker ◽

B. Jönsson

Keyword(s):

Recurrent Major Depressive Disorder

Depressive Disorder ◽

Maintenance Treatment ◽

Cost Utility ◽

Major Depressive ◽

The Cost ◽

Major depressive disorder: similar remission rates with bupropion, sertraline, or venlafaxine following treatment switch from citalopram

Evidence-Based Mental Health ◽

10.1136/ebmh.9.4.100 ◽

2006 ◽

Vol 9 (4) ◽

pp. 100-100 ◽

Cited By ~ 5

Author(s):

G. I Papakostas

Keyword(s):

Depressive Disorder ◽

Major Depressive ◽

Remission Rates ◽

Treatment Switch

Cost-Utility Analyses of Cognitive-Behavioral Therapy for Major Depressive Disorder – A Systematic Review

Value in Health ◽

10.1016/j.jval.2013.08.1415 ◽

2013 ◽

Vol 16 (7) ◽

pp. A549

Author(s):

C. Brettschneider ◽

H.H. König

Keyword(s):

Systematic Review ◽

Cognitive Behavioral Therapy ◽

Depressive Disorder ◽

Behavioral Therapy ◽

Cost Utility ◽

Cognitive Behavioral ◽

Cost-Utility of Vortioxetine in the Treatment of Major Depressive Disorder: Comparison with Agomelatine, Bupropion, Sertraline and Venlafaxine in the Finnish Setting

Value in Health ◽

10.1016/j.jval.2014.08.1267 ◽

2014 ◽

Vol 17 (7) ◽

pp. A459 ◽

Cited By ~ 2

Author(s):

E.J. Soini ◽

T. Hallinen ◽

M. Brignone ◽

N. Despiégel ◽

M. Aalto-Setälä ◽

...

Keyword(s):

Depressive Disorder ◽

Cost Utility ◽

Cost-utility evaluation of vortioxetine in patients with Major Depressive Disorder experiencing inadequate response to alternative antidepressants in the United Kingdom

Journal of Affective Disorders ◽

10.1016/j.jad.2017.04.019 ◽

2017 ◽

Vol 218 ◽

pp. 291-298 ◽

Cited By ~ 3

Author(s):

A.H. Young ◽

L. Evitt ◽

M. Brignone ◽

F. Diamand ◽

K. Atsou ◽

...

Keyword(s):

United Kingdom ◽

Depressive Disorder ◽

Cost Utility ◽

Inadequate Response ◽

Major Depressive ◽

The United Kingdom ◽

Utility Evaluation